Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer OTC Drugs

Rexall Sundown Cellasene Claims Cited In FTC Complaint

This article was originally published in The Tan Sheet

  • News
  • The Tan Sheet

Executive Summary

Claims made by Rexall Sundown in support of its Cellasene cellulite-reducing dietary supplement are "false and misleading," the Federal Trade Commission charges in a July 19 complaint.

You may also be interested in...



Weider FTC Weight Loss Charges Settled For $400,000

Weider Nutrition Internatl. has agreed to pay $400,000 to settle Federal Trade Commission charges the firm misrepresented the science supporting weight loss and safety claims for its Schiff PhenCal products.

Weider FTC Weight Loss Charges Settled For $400,000

Weider Nutrition Internatl. has agreed to pay $400,000 to settle Federal Trade Commission charges the firm misrepresented the science supporting weight loss and safety claims for its Schiff PhenCal products.

Weider FTC Weight Loss Charges Settled For $400,000

Weider Nutrition Internatl. has agreed to pay $400,000 to settle Federal Trade Commission charges the firm misrepresented the science supporting weight loss and safety claims for its Schiff PhenCal products.

Table

View full table

Related Content

Pink Sheet

Topics

Tags:
Consumer OTC Drugs
Latest Headlines

Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification

US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios

FTC Early Findings In PBM Investigation Coming By Mid-Summer, Chair Kahn Says

New EU Filings

See All
UsernamePublicRestriction

Register

PS091469

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By